透過您的圖書館登入
IP:216.73.216.100
  • 期刊
  • OpenAccess

Mirtazapine for Treatment of Drug-Resistant Pathological Skin Picking

Mirtazapine用於治療難治型病態性搔抓症

並列摘要


Objective: Pathological skin-picking (PSP) is a common disorder, and some pharmocotherapies for PSP have been reported. But the appropriate treatment is limited. We are reporting the use of mirtazapine to successfully treat a refractory PSP case. Case Report: This 42-year-old woman patient with mental retardation had suffered from treatment-refractory PSP for at least ten years. She had received behavioral therapies and various pharmacologic agents, including several kinds of antidepressants, topiramate, and lamotrigene. But she had got only minimal improvement. After receiving mirtazapine 30 mg/day for one week, the patient's PSP was dramatically improved. Conclusion: Mirtazapine showed to have improved PSP in this patient. More well-designed studies are needed to definitely prove the effect and neurobiologic actions of mirtazapine in PSP.

參考文獻


Grant, JE,Odlaug, BL(2009).Update on pathological skin picking.Curr Psychiatry Rep.11,283-8.
Bloch, MR,Elliott, M,Thompson, H,Koran, LM(2001).Fluoxetine in pathologic skin-picking: open-label and double-blind results.Psychosomatics.42,314-9.
Arbabi, M,Farnia, V,Balighi, K(2008).Efficacy of citalopram in treatment of pathological skin picking, a randomized double blind placebo controlled trial.Acta Medica Iranica.46,367-72.
Keuthen, NJ,Jameson, M,Loh, R(2007).Open-label escitalopram treatment for pathological skin picking.Int Clin Psychopharmacol.22,268-74.
Croom, KF,Perry, CM,Plosker, GL(2009).Mirtazapine: a review of its use in major depression and other psychiatric disorders.CNS Drugs.23,427-52.

延伸閱讀